A genetic model for in vivo proximity labelling of the mammalian secretome
- Creators
- Yang, Rui1
- Meyer, Amanda S.1
- Droujinine, Ilia A.2
- Udeshi, Namrata D.3
- Hu, Yanhui4
- Guo, Jinjin1
- McMahon, Jill A.1
- Carey, Dominique K.3
- Xu, Charles3
- Fang, Qiao5
- Sha, Jihui6
- Qin, Shishang7
- Rocco, David4
- Wohlschlegel, James6
- Ting, Alice Y.8, 9
- Carr, Steven A.3
- Perrimon, Norbert4, 10
- McMahon, Andrew P.1
Abstract
Organ functions are highly specialized and interdependent. Secreted factors regulate organ development and mediate homeostasis through serum trafficking and inter-organ communication. Enzyme-catalysed proximity labelling enables the identification of proteins within a specific cellular compartment. Here, we report a BirA*G3 mouse strain that enables CRE-dependent promiscuous biotinylation of proteins trafficking through the endoplasmic reticulum. When broadly activated throughout the mouse, widespread labelling of proteins was observed within the secretory pathway. Streptavidin affinity purification and peptide mapping by quantitative mass spectrometry (MS) proteomics revealed organ-specific secretory profiles and serum trafficking. As expected, secretory proteomes were highly enriched for signal peptide-containing proteins, highlighting both conventional and non-conventional secretory processes, and ectodomain shedding. Lower-abundance proteins with hormone-like properties were recovered and validated using orthogonal approaches. Hepatocyte-specific activation of BirA*G3 highlighted liver-specific biotinylated secretome profiles. The BirA*G3 mouse model demonstrates enhanced labelling efficiency and tissue specificity over viral transduction approaches and will facilitate a deeper understanding of secretory protein interplay in development, and in healthy and diseased adult states.
Copyright and License
© 2022 The Authors. Published by the Royal Society under the terms of the Creative Commons AttributionLicense http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the originalauthor and source are credited.
Acknowledgement
We thank the Janelia Gene Targeting and Transgenics Facility (Director: Caiying Guo) for the BirA*G3 mouse generation. We thank Peter Calabrese and Ivy Xiong from University of Southern California (USC), Pierre Michel Jean Beltran from Broad Institute, Xianwen Ren from Peking University, Kevin Blighe from Rancho BioSciences, and Geetu Tuteja from Iowa State University for help with mass spectrometry data analysis. We thank Jeffrey Boyd and Bernadette Masinsin from the Flow Cytometry Facility of Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research at USC for assisting with hepatocyte sorting. We thank Seth Ruffins from Optical Imaging Facility and Riana Parvez of Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research at USC for assisting with fluorescence imaging. We thank Genome Technology Access Center from Washington University for performing bulk RNA-seq.
Funding
This work was supported by a NIH Transformative R01 grant 5R01DK121409 to A.P.M., A.Y.T., S.A.C. and N.P., and HHMI funding to N.P. I.A.D. acknowledges support from the Ellen Browning Scripps Foundation.
Contributions
R.Y.: conceptualization, data curation, investigation, software, validation, visualization, writing—original draft; A.S.M.: conceptualization, data curation, investigation, software, validation, visualization, writing—original draft; I.A.D.: conceptualization, data curation, software, writing—original draft, writing—review and editing; N.D.U.: conceptualization, data curation, formal analysis, methodology, software; Y.H.: methodology, software, visualization; J.G.: data curation, validation, visualization; J.A.M.: conceptualization, data curation, project administration, visualization; D.K.C.: data curation, methodology, software, visualization; C.X.: data curation, software, visualization; Q.F.: software, visualization; J.S.: data curation, methodology, software; S.Q.: software, visualization; D.R.: data curation, visualization; J.W.: data curation, methodology, writing—review and editing; A.Y.T.: conceptualization, methodology, writing—review and editing; S.A.C.: methodology, software, writing—review and editing; N.P.: conceptualization, project administration, writing—review and editing; A.P.M.: conceptualization, methodology, project administration, writing—original draft, writing—review and editing.
All authors gave final approval for publication and agreed to be held accountable for the work performed therein.
Data Availability
The original mass spectra and the protein sequence databases used for searches have been deposited in the public proteomics repository MassIVE (http://massive.ucsd.edu) and are accessible at ftp://MSV000088848@massive.ucsd.edu. RNA sequencing data is available under BioProject PRJNA808087 from NCBI SRA at https://www.ncbi.nlm.nih.gov/sra. The following public databases were used: Uniprot (https://www.uniprot.org), mouse (https://www.uniprot.org/proteomes/UP000000589), SignalP 5.0 (https://services.healthtech.dtu.dk/service.php?SignalP-5.0), TMHMM 2.0 (https://services.healthtech.dtu.dk/service.php?TMHMM-2.0). All analysis code is available at https://github.com/asmeyer/A-genetic-model-for-in-vivo-proximity-labeling-of-the-mammalian-secretome.git. Corresponding authors will provide original data upon request. Source data are provided with this paper.
The data are provided in electronic supplementary material [62].
Conflict of Interest
A.P.M. is a scientific adviser for Novartis, TRESTLE BioTherapeutics, eGENESIS and IVIVA Medical. S.A.C. is a member of the scientific advisory boards of Kymera, PTM BioLabs, Seer and PrognomIQ. A.Y.T. declares intellectual property interests around proximity labelling technology.
Ethics
Institutional Animal Care and Use Committees (IACUC) at the University of Southern California reviewed and approved all animal work as performed in this study. All work adhered to institutional guidelines.
Supplemental Material
Supplementary material and data sets available on figshare: https://doi.org/10.6084/m9.figshare.c.6125239.v1
- PDF includes Supplemental Figs. 1-16 and Supplementary Tables 1-2.
- Other Supplementary Files for this manuscript include the following: Supplementary Data 1-6
Files
Name | Size | Download all |
---|---|---|
md5:73ad58c8e6d22841d072eda22c4e1de2
|
25.0 MB | Preview Download |
md5:bc3b670b38bb5ee646bac0319b1194f4
|
2.1 MB | Preview Download |
Additional details
- NIH
- 5R01DK121409
- Howard Hughes Medical Institute
- Accepted
-
2022-07-20Accepted
- Available
-
2022-10-08Published online
- Caltech groups
- Division of Biology and Biological Engineering
- Publication Status
- Published